Standardization of Recombinant CRISPR/Cas13a-nuclease Preparations by Using RNase A of Known Activity
Main Article Content
Abstract
The approach to characterize preparations of recombinant Cas13a-nuclease in terms of specific collateral activity has been proposed for standardization of enzyme preparations. The standardization of Cas13a preparations by the specific activity may benefit both the development of assays employing Cas13a collateral ribonuclease activity and the optimization of ribonuclease expression, purification, and storage. The approach is based on measurement of the initial rate of a cleavage of specially designed commercially available RNA molecules (“reporters” labelled with a fluorophore and a quencher) by a preparation of recombinant Cas13a-nuclease and commercial RNase A of known activity. This requires the optimization of a molar ratio for the formation of Cas13a complexes with guide RNA as well as the optimization of amount of the RNA target. The use of a synthetic RNA target appears preferable compared with total RNA preparations.
Article Details
References
- Zamani, M., Furst, A.L., Klapperich,C.M. (2021) Strategies for engineering affordable technologies for point-of-care diagnostics of infectious diseases. Accounts of Chemical Research, 54(20), 3772-3779. DOI
- Ivanov, A.V., Safenkova, I.V., Zherdev, A.V., Dzantiev, B.B. (2021) The potential use of isothermal amplification assays for in-field diagnostics of plant pathogens. Plants (Basel), 10(11), 2424. DOI
- Zhao, Y., Chen, F., Li Q., Wang, L., Fan, C. (2015) Isothermal Amplification of Nucleic Acids. Chemical Reviews, 115(22), 12491-12545. DOI
- van Dongen, J.E., Berendsen, J.T.W., Steenbergen, R.D.M., Wolthuis, R.M.F., Eijkel, J.C.T., Segerink, L.I. (2020) Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities. Biosensors and Bioelectronics, 166, 112445. DOI
- Kaminski, M.M., Abudayyeh, O.O., Gootenberg, J.S., Zhang, F., Collins, J.J. (2021) CRISPR-based diagnostics. Nature Biomedical Engineering, 5(7), 643–656. DOI
- Ozay, B., McCalla, S.E. (2021) A review of reaction enhancement strategies for isothermal nucleic acid amplification reactions. Sensors and Actuators Reports, 3, 100033. DOI
- Wu, W.Y., Lebbink, J.H.G., Kanaar, R., Geijsen, N., van der Oost, J. (2018) Genome editing by natural and engineered CRISPR-associated nucleases. Nature Chemical Biology, 14(7), 642-651. DOI
- Kim, S., Ji, S., Koh, H.R. (2021) CRISPR as a Diagnostic Tool. Biomolecules, 11(8), 1162. DOI
- Abudayyeh, O.O., Gootenberg, J.S., Konermann, S., Joung, J., Slaymaker, I.M., Cox, D.B., Shmakov, S., Makarova, K.S., Semenova, E., Minakhin, L., Severinov, K., Regev, A., Lander, E.S., Koonin, E.V., Zhang, F. (2016) C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 353(6299), aaf5573. DOI
- Gootenberg, J.S., Abudayyeh, O.O., Lee, J.W., Essletzbichler, P., Dy, A.J., Joung, J., Verdine, V., Donghia, N., Daringer, N.M., Freije, C.A., Myhrvold, C., Bhattacharyya, R.P., Livny, J., Regev, A., Koonin, E.V., Hung, D.T., Sabeti, P.C., Collins, J.J., Zhang, F. (2017) Nucleic acid detection with CRISPR-Cas13a/C2c2. Science, 356(6336), 438-442. DOI
- Kurbatov, L.K., Radko, S.P., Kravchenko, S.V., Kiseleva, O.I., Durmanov, N.D., Lisitsa, A.V. (2020) Single stage purification of CRISPR/cas13a nuclease via metal-chelating chromatography following heterologous expression with the preservation of collateral ribonuclease activity. Applied Biochemistry and Microbiology, 56(6), 671–677. DOI
- Zhu, H., Richmond, E., Liang, C. (2018) CRISPR-RT: A web application for designing CRISPR-C2c2 crRNA with improved target specificity. Bioinformatics, 34(1), 117-119. DOI
- Bisswanger, H. (2013) Practical Enzymology. Wiley-Blackwell, 376 p.
- Polygina, G.V., Cherednichenko, V.S., Rimareva, L.V. (2003) Opredelenie aktivnosti fermentov. DeLi print, Moscow, 376 p.